Endometrial sampling devices for early diagnosis of endometrial lesions

Endometrial Sampling

Endometrial Sampling

Interpretation of Endometrial Lesions and Infertility in Mares

Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management

Globally, endometrial cancer is the sixth leading cause of female cancer-related deaths. Non-atypical endometrial hyperplasia (EH), has a lifetime progression rate to endometrial cancer ranging from less than 5%, if simple without atypia, to 40%, if complex with atypia. Site specific, long-acting intrauterine devices (IUDs) provide fertility sparing, progestin-based EH medical management. It is...

Endometrial sampling in general practice.

Unexpected vaginal bleeding is a common problem in general medical practice and likely to increase as more women use hormone replacement therapies (HRT). This study looks at the successful introduction of a technique for endometrial sampling into general practice, allowing earlier diagnosis of endometrial cancer and reassurance for women without serious pathology.